- Corporate Officers - A
- Adelman Burt A
Insider Trading History of Adelman Burt A
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Adelman Burt A since 2005.
This trader's CIK number is 1226283.
At the time of last reporting, Adelman Burt A was the Director of Verve Therapeutics, Inc.. (stock ticker symbol VERV).
Also see all insider trading activities at Verve Therapeutics, Inc..
Note that in the past
ADELMAN BURT A also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Biogen Inc. (BIIB) by Adelman Burt A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | BIIB | 0 | $0 | 316,730 | $20,170,597 | 303,692 | $15,202,221 |
| 2006 | BIIB | 0 | $0 | 121,848 | $5,489,725 | 103,500 | $3,050,145 |
| 2005 | BIIB | 0 | $0 | 20,500 | $914,915 | 20,500 | $346,449 |
Yearly summary of insider trading at Verve Therapeutics, Inc. (VERV) by Adelman Burt A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | VERV | 14,000 | $207,066 | 0 | $0 | 0 | $0 |
| 2021 | VERV | 4,700 | $147,302 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Dyax Corp (DYAX) by Adelman Burt A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | DYAX | 0 | $0 | 0 | $0 | 142,977 | $322,699 |
| 2015 | DYAX | 0 | $0 | 84,375 | $1,200,740 | 112,500 | $166,500 |
| 2014 | DYAX | 0 | $0 | 55,000 | $532,400 | 55,000 | $81,400 |
Insider trading activities at 3 companies by Adelman Burt A:
1. Biogen Inc. (BIIB)
2. Verve Therapeutics, Inc. (VERV)
3. Dyax Corp (DYAX)
Table 1. Insider trading of Biogen Inc. (BIIB) by Adelman Burt A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-10-15 | BIIB | Option Ex | 60,500 | 64.92 | 3,927,962 |
| 2007-10-15 | BIIB | Sale | 60,500 | 82.00 | 4,961,000 |
| 2007-08-30 | BIIB | Option Ex | 46,000 | 49.03 | 2,255,380 |
| 2007-08-30 | BIIB | Sale | 46,000 | 64.03 | 2,945,380 |
| 2007-08-27 | BIIB | Option Ex | 8,750 | 43.50 | 380,625 |
| 2007-08-27 | BIIB | Sale | 8,750 | 63.50 | 555,625 |
| 2007-08-17 | BIIB | Option Ex | 28,750 | 45.46 | 1,306,975 |
| 2007-08-17 | BIIB | Sale | 28,750 | 60.46 | 1,738,253 |
| 2007-07-25 | BIIB | Option Ex | 29,000 | 40.48 | 1,173,775 |
| 2007-07-26 | BIIB | Option Ex | 115,000 | 49.61 | 5,705,150 |
| 2007-07-25 | BIIB | Sale | 29,000 | 57.98 | 1,681,275 |
| 2007-07-26 | BIIB | Sale | 115,000 | 59.61 | 6,855,150 |
| 2007-07-03 | BIIB | Option Ex | 10,225 | 44.24 | 452,354 |
| 2007-07-03 | BIIB | Sale | 10,225 | 54.24 | 554,604 |
| 2007-03-20 | BIIB | Sale | 6,634 | 44.48 | 295,067 |
| 2007-02-13 | BIIB | Sale | 11,871 | 49.22 | 584,243 |
| 2007-02-06 | BIIB | Option Ex | 5,467 | .00 | 0 |
| 2006-09-19 | BIIB | Sale | 18,348 | 42.76 | 784,615 |
| 2006-01-03 | BIIB | Option Ex | 103,500 | 29.47 | 3,050,145 |
| 2006-01-03 | BIIB | Sale | 103,500 | 45.46 | 4,705,110 |
| 2005-12-28 | BIIB | Option Ex | 20,500 | 16.90 | 346,449 |
| 2005-12-28 | BIIB | Sale | 20,500 | 44.63 | 914,915 |
Table 2. Insider trading of Verve Therapeutics, Inc. (VERV) by Adelman Burt A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-05-12 | VERV | Buy | 10,000 | 12.15 | 121,530 |
| 2022-03-15 | VERV | Buy | 4,000 | 21.38 | 85,536 |
| 2021-12-02 | VERV | Buy | 4,700 | 31.34 | 147,302 |
Table 3. Insider trading of Dyax Corp (DYAX) by Adelman Burt A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-01-13 | DYAX | Option Ex | 142,977 | 2.26 | 322,699 |
| 2015-12-22 | DYAX | Option Ex | 10,000 | 1.48 | 14,800 |
| 2015-12-17 | DYAX | Option Ex | 27,500 | 1.48 | 40,700 |
| 2015-03-05 | DYAX | Sale | 9,375 | 15.66 | 146,840 |
| 2015-01-02 | DYAX | Sale | 75,000 | 14.05 | 1,053,900 |
| 2015-01-02 | DYAX | Option Ex | 75,000 | 1.48 | 111,000 |
| 2014-03-03 | DYAX | Option Ex | 55,000 | 1.48 | 81,400 |
| 2014-03-03 | DYAX | Sale | 55,000 | 9.68 | 532,400 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Adelman Burt A
(Director of Verve Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.